Roger E. Susi's Sale of IRADIMED CORP Common Stock

Roger E. Susi, the CEO, President, and Chairman of IRADIMED CORP, reported the sale of 5,000 shares of common stock on October 27, 2025. The sales were executed in multiple trades at prices ranging from $76.99 to $79.16, with weighted average prices reported for each transaction. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by Susi on June 16, 2025. Following these transactions, Susi's total ownership in IRADIMED CORP stands at 2,327,500 shares, held indirectly through various trusts. Susi disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.